Search

everythinglearnresearchcommunity

for

Search:↓

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

The study found that in Latin America, ancestry varies by location, influences physical traits, and affects how people perceive their own heritage.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

H1 increases risk for neurodegenerative diseases, while H2 offers protection but is linked to other disorders.

Omega-6 and LDL cholesterol increase the risk of hair loss.

Psychological and social responses to scars can indicate mental health risks.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Over 67 genes linked to ichthyosis help improve diagnosis and treatment.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Diet changes can protect against harmful environmental effects on fetal development.

Nociplastic pain is a complex, heritable trait with genetic links to chronic and neuropathic pain.

Understanding embryologic layers improves skin disorder diagnosis and supports developing targeted therapies.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Entrepreneurial companies are key to advancing dermatology treatments and patient care.

Herbal shampoos are effective, non-toxic alternatives for treating dandruff and hair fall.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.